ABEO vs XBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

ABEO

55.3
AI Score
VS
ABEO Wins

XBIO

46.5
AI Score

Investment Advisor Scores

ABEO

55score
Recommendation
HOLD

XBIO

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ABEO XBIO Winner
Revenue 20.10M 1.47M ABEO
Net Income -37.27M -1.39M XBIO
Net Margin -185.4% -94.5% XBIO
Operating Income -36.69M -1.47M XBIO
ROE -29.1% -22.8% XBIO
ROA -20.8% -19.9% XBIO
Total Assets 179.51M 6.97M ABEO
Current Ratio 6.63 7.43 XBIO

Relative Price Performance (Last 90 Days)

ABEO 1M: -19.0% · 3M: -28.2% XBIO 1M: -30.4% · 3M: -31.2%

Current Technical Phase

ABEO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -12.0%), weak momentum, RSI 33

RSI (14): 33.1 · Price: $4.40

XBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.6%), weak momentum, RSI 28

RSI (14): 27.7 · Price: $1.72

Fundamentals Snapshot

Metric ABEO XBIO
Market Cap — —
Forward P/E -21.2 -5.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 27.5% 0.1%
Gross Margin -0.4% 1.0%
Operating Margin -1.2% -1.5%
EPS -1.18 -1.09
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ABEO is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.